6-Phenoxy-2-phenylbenzoxazoles, novel inhibitors of receptor for advanced glycation end products (RAGE)
- 1 August 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (15) , 4919-4935
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology
- Korea Science and Engineering Foundation (NRF-2009-0081669)
This publication has 29 references indexed in Scilit:
- The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and FibrillizationChemical Reviews, 2012
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer diseaseJournal of Clinical Investigation, 2012
- Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersNature Reviews Neuroscience, 2011
- RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunctionProceedings of the National Academy of Sciences, 2009
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- RAGE Mediates a Novel Proinflammatory AxisCell, 1999
- Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer.Journal of Clinical Investigation, 1998
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for AmphoterinJournal of Biological Chemistry, 1995
- Blood-Brain Barrier Transport of Circulating Alzheimer′s Amyloid βBiochemical and Biophysical Research Communications, 1993